SCM Lifescience
Incheon, Incheonscmlifescience.com
Overview
SCM Lifescience is a publicly traded South Korean biopharmaceutical company that develops stem cell therapeutics for a variety of immune-related and incurable diseases using its proprietary subfractionation culturing method. The company's strategy includes 'open innovation', where it expands its pipeline through strategic equity investments, joint ventures, and acquisitions of other biotechnology firms. It also provides CMO services for stem cell production.
Portfolio Companies
2
Website
scmlifescience.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Vita Therapeutics | Jun 2021 | Series A | Co-investor |
| CoImmune, Inc. | Nov 2020 | Series A | Co-investor |
| CoImmune, Inc. | Feb 2019 | Corporate Funding | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
